These studies underscore a widespread pattern of COL11A1 upregulation across a diverse array of malignancies, encompassing adrenal cortical carcinoma, urothelial bladder carcinoma, invasive breast cancer, cervical squamous and adenocarcinoma, cholangiocarcinoma, and colon adenocarcinoma [14]. This evidence concerns the gene COL11A1 and bladder transitional cell carcinoma.